Inflammation-based prognostic score in patients with living donor liver transplantation for hepatocellular carcinoma

Norifumi Harimoto, Tomoharu Yoshizumi, Tomonari Shimagaki, Akihisa Nagatsu, Takashi Motomura, Noboru Harada, Hirohisa Okabe, Shinji Itoh, Toru Ikegami, Hideaki Uchiyama, Yuji Soejima, Yoshihiko Maehara

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Inflammation-besed prognostic score including neutrophil/lymphocyte ratio (NLR), platelet/ lymphocyte ratio (PLR), modified Glasgow prognostic score (mGPS) and prognostic nutritional index (PNI) have prognostic value in various malignancies. Patients and Methods: We retrospectively investigated their prognostic value in 213 patients with living donor liver transplantation (LDLT) for hepatocellular carcinoma (HCC). Disease-free survival (DFS) following LDLT was calculated; NLR, PLR, PNI and mGPS values in patients with and without recurrence were compared. Risk factors for HCC recurrence were identified by univariate and multivariate analyses. Results: Both NLR and PLR were significantly increased in patients with recurrence. Multivariate analysis showed that desgamma-carboxy prothrombin (DCP) 300 mAU/ml, NLR 2.66, <3 months between last HCC treatment to LDLT were independent predictors of DFS. Conclusion: Preoperative NLR was an independent, inflammation-based prognostic marker of DFS and was predictive of recurrence following LDLT.

Original languageEnglish
Pages (from-to)5537-5542
Number of pages6
JournalAnticancer research
Volume36
Issue number10
DOIs
Publication statusPublished - Oct 2016

Fingerprint

Living Donors
Liver Transplantation
Hepatocellular Carcinoma
Lymphocytes
Inflammation
Neutrophils
Disease-Free Survival
Recurrence
Nutrition Assessment
Blood Platelets
Multivariate Analysis
Prothrombin

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Inflammation-based prognostic score in patients with living donor liver transplantation for hepatocellular carcinoma. / Harimoto, Norifumi; Yoshizumi, Tomoharu; Shimagaki, Tomonari; Nagatsu, Akihisa; Motomura, Takashi; Harada, Noboru; Okabe, Hirohisa; Itoh, Shinji; Ikegami, Toru; Uchiyama, Hideaki; Soejima, Yuji; Maehara, Yoshihiko.

In: Anticancer research, Vol. 36, No. 10, 10.2016, p. 5537-5542.

Research output: Contribution to journalArticle

Harimoto, Norifumi ; Yoshizumi, Tomoharu ; Shimagaki, Tomonari ; Nagatsu, Akihisa ; Motomura, Takashi ; Harada, Noboru ; Okabe, Hirohisa ; Itoh, Shinji ; Ikegami, Toru ; Uchiyama, Hideaki ; Soejima, Yuji ; Maehara, Yoshihiko. / Inflammation-based prognostic score in patients with living donor liver transplantation for hepatocellular carcinoma. In: Anticancer research. 2016 ; Vol. 36, No. 10. pp. 5537-5542.
@article{cef0572a86914cf9b130633544a90bec,
title = "Inflammation-based prognostic score in patients with living donor liver transplantation for hepatocellular carcinoma",
abstract = "Background: Inflammation-besed prognostic score including neutrophil/lymphocyte ratio (NLR), platelet/ lymphocyte ratio (PLR), modified Glasgow prognostic score (mGPS) and prognostic nutritional index (PNI) have prognostic value in various malignancies. Patients and Methods: We retrospectively investigated their prognostic value in 213 patients with living donor liver transplantation (LDLT) for hepatocellular carcinoma (HCC). Disease-free survival (DFS) following LDLT was calculated; NLR, PLR, PNI and mGPS values in patients with and without recurrence were compared. Risk factors for HCC recurrence were identified by univariate and multivariate analyses. Results: Both NLR and PLR were significantly increased in patients with recurrence. Multivariate analysis showed that desgamma-carboxy prothrombin (DCP) 300 mAU/ml, NLR 2.66, <3 months between last HCC treatment to LDLT were independent predictors of DFS. Conclusion: Preoperative NLR was an independent, inflammation-based prognostic marker of DFS and was predictive of recurrence following LDLT.",
author = "Norifumi Harimoto and Tomoharu Yoshizumi and Tomonari Shimagaki and Akihisa Nagatsu and Takashi Motomura and Noboru Harada and Hirohisa Okabe and Shinji Itoh and Toru Ikegami and Hideaki Uchiyama and Yuji Soejima and Yoshihiko Maehara",
year = "2016",
month = "10",
doi = "10.21873/anticanres.11137",
language = "English",
volume = "36",
pages = "5537--5542",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "10",

}

TY - JOUR

T1 - Inflammation-based prognostic score in patients with living donor liver transplantation for hepatocellular carcinoma

AU - Harimoto, Norifumi

AU - Yoshizumi, Tomoharu

AU - Shimagaki, Tomonari

AU - Nagatsu, Akihisa

AU - Motomura, Takashi

AU - Harada, Noboru

AU - Okabe, Hirohisa

AU - Itoh, Shinji

AU - Ikegami, Toru

AU - Uchiyama, Hideaki

AU - Soejima, Yuji

AU - Maehara, Yoshihiko

PY - 2016/10

Y1 - 2016/10

N2 - Background: Inflammation-besed prognostic score including neutrophil/lymphocyte ratio (NLR), platelet/ lymphocyte ratio (PLR), modified Glasgow prognostic score (mGPS) and prognostic nutritional index (PNI) have prognostic value in various malignancies. Patients and Methods: We retrospectively investigated their prognostic value in 213 patients with living donor liver transplantation (LDLT) for hepatocellular carcinoma (HCC). Disease-free survival (DFS) following LDLT was calculated; NLR, PLR, PNI and mGPS values in patients with and without recurrence were compared. Risk factors for HCC recurrence were identified by univariate and multivariate analyses. Results: Both NLR and PLR were significantly increased in patients with recurrence. Multivariate analysis showed that desgamma-carboxy prothrombin (DCP) 300 mAU/ml, NLR 2.66, <3 months between last HCC treatment to LDLT were independent predictors of DFS. Conclusion: Preoperative NLR was an independent, inflammation-based prognostic marker of DFS and was predictive of recurrence following LDLT.

AB - Background: Inflammation-besed prognostic score including neutrophil/lymphocyte ratio (NLR), platelet/ lymphocyte ratio (PLR), modified Glasgow prognostic score (mGPS) and prognostic nutritional index (PNI) have prognostic value in various malignancies. Patients and Methods: We retrospectively investigated their prognostic value in 213 patients with living donor liver transplantation (LDLT) for hepatocellular carcinoma (HCC). Disease-free survival (DFS) following LDLT was calculated; NLR, PLR, PNI and mGPS values in patients with and without recurrence were compared. Risk factors for HCC recurrence were identified by univariate and multivariate analyses. Results: Both NLR and PLR were significantly increased in patients with recurrence. Multivariate analysis showed that desgamma-carboxy prothrombin (DCP) 300 mAU/ml, NLR 2.66, <3 months between last HCC treatment to LDLT were independent predictors of DFS. Conclusion: Preoperative NLR was an independent, inflammation-based prognostic marker of DFS and was predictive of recurrence following LDLT.

UR - http://www.scopus.com/inward/record.url?scp=84991824055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991824055&partnerID=8YFLogxK

U2 - 10.21873/anticanres.11137

DO - 10.21873/anticanres.11137

M3 - Article

C2 - 27798927

AN - SCOPUS:84991824055

VL - 36

SP - 5537

EP - 5542

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 10

ER -